The local medical community is abuzz with the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist showing significant results in clinical trials for managing obesity. This medication https://hotbookmarkings.com/story21765329/retatrutide-australia-a-emerging-solution-for-weight-loss